The Life Sciences Law Review — France
Medicines and medical devices are regulated mainly under the Public Health Code (CSP), which deals with a wide array of matters such as clinical trials, marketing authorisations and CE-marking, manufacturing and distribution, advertising, and relationships with health-care professionals. The Social Security Code (CSS) also contains several provisions focusing on pricing and reimbursement.
This legal framework is complemented by a variety of governmental decrees and decisions of the health authorities, as well as agreements between authorities and representatives of the industry (e.g., for reimbursement).
The main authorities involved in enforcing the medicines and medical device regulations are as described below.
The National Security Agency of Medicines and Health Products (ANSM) has a wide role that includes inter alia the following topics:
- clinical trial authorisations;
- marketing authorisations and pharmacovigilance and materiovigilance;
- analysing the risk-benefit balance of health products during their life cycle;
- authorisation and monitoring of pharmaceutical establishments; and
- advertising of medicines and medical devices…
If you are registered and logged in to the site, click on the link below to read the rest of the Hogan Lovells briefing. If not, please register or sign in with your details below.
News from Hogan Lovells
News from The Lawyer
Briefings from Hogan Lovells
The decision of the US Court of Appeals has raised questions about how issuers should present their disclosures on conflict minerals under Exchange Act Rule 13p-1 and Form SD.
An interesting judgment was delivered by the Honourable J Majiki on 19 November 2013 in the Eastern Cape High Court, Port Elizabeth.
Analysis from The Lawyer
As international firms question their future in these small, closely linked markets, local lawyers too are eyeing the business environment with caution
Beyond the headline infrastructure projects, UK construction work is still recovering from the clobbering it took during the slump